Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Shylendra B Sreenivasappa"'
Autor:
Amy Chadburn, Shylendra B Sreenivasappa, Victoria Angelova, Paul G. Rubinstein, Marina Messinger, Ingrid Sumpter, Ariela Noy, Adam M. Petrich, Shweta Gupta, Ethel Cesarman, Locke J. Bryan, Jonathan Moreira
Publikováno v:
Blood. 122:2996-2996
Introduction Studies of EBV positive (+) and negative (-) classical Hodgkin lymphoma (cHL) have shown the importance of the immune microenvironment in affecting Reed-Sternberg (hRS) cell survival, proliferation, and biologic behavior. For example, ma
Autor:
Shivi Jain, Sylvia Velinova, Manila Gaddh, Shylendra B Sreenivasappa, Rosalind Catchatourian, Peter Ruestow, Mousami Shah, Margaret Telfer, Barabara Yim, Shweta Gupta, Dayra Avila, Thomas E. Lad, Tareq Braik, Paul G. Rubinstein
Publikováno v:
Blood. 118:5118-5118
Abstract 5118 Introduction: Since the mid 1990s, high dose chemotherapy with hematopoietic stem cell rescue has been considered the standard of care for front-line treatment in younger patients with multiple myeloma. This standard of care has been ba
Autor:
Shivi Jain, Shweta Gupta, Margaret Telfer, Audrey L. French, Shinoj Pattali, Paul G. Rubinstein, Shylendra B Sreenivasappa, Tareq Braik, Sonia Sandhu
Publikováno v:
Blood. 118:3693-3693
Abstract 3693 Introduction: Stroger Hospital of Cook County (CCH) and the Ruth M. Rothstein CORE Center (CC) are the largest health provider for HIV + patients in Chicago and one of the largest in the United States. Together, the CC and CCH treats ov
Autor:
Audrey L. French, S. Velinova, Shweta Gupta, Margaret Clare Telfer, Kunnal Batra, J. M. Orsi, Shylendra B Sreenivasappa, H. V. Poola, Michael Russell Mullane, Shivi Jain, Paul G. Rubinstein
Publikováno v:
Journal of Clinical Oncology. 29:1551-1551
1551 Background: CCH is the largest health provider for HIV patients in Chicago and has one of the largest HIV outpatient clinics in the United States, the Ruth M. Rothstein CORE Center (CC). Per y...
Autor:
Barbara Yim, Anne Navaleza, Rose Catchatourian, Moushmi Shah, Margaret Telfer, Paul G. Rubinstein, Augustin Haidau, Manila Gaddh, Shylendra B Sreenivasappa, Tareq Braik, Mohammed A. Kassem, Bety Ciobanu
Publikováno v:
Blood. 116:1779-1779
Abstract 1779 Introduction: Tumor Lysis Syndrome (TLS) is an oncologic emergency that leads to a host of metabolic disturbances which can ultimately result in acute renal failure and death. Currently rasburicase, Elitek™, is FDA approved for the tr
Publikováno v:
Journal of Clinical Oncology. 28:1600-1600
1600 Background: The recurrence pattern of women with early stage breast cancer (ESBC) in ethnic minority, treated as per current guidelines is not well known. Methods: Women diagnosed with ESBC in...
Publikováno v:
Blood. 114:4757-4757
Abstract 4757 Background The response of patients with relapse/refractory (s/p CHOPR) Diffuse large B Cell Lymphoma (DLBCL) to RICE chemotherapy in transplant ineligible patients (pts) is not well studied. Methods 28 consecutive pts with DLBCL, relap
Publikováno v:
Blood. 114:4465-4465
Abstract 4465 Background Immune Thrombocytopenic Purpura (ITP) is a common hematological disorder. We sort to characterize the risk profiles and efficacy of anti D immunoglobulin in chronic ITP in a largely minority cohort. Methods 31 patients (pts)
Publikováno v:
Blood. 114:4791-4791
Abstract 4791 Background Response and factors affecting response in patients with aggressive Non Hodgkin's Gastro Intestinal (GI) tract lymphoma to upfront Rituximab based chemotherapy is not well characterized. Methods 41 consecutive pts diagnosed a
Autor:
Mousami Shah, Michael Russell Mullane, Bety Ciobanu, Barbara Yim, Shylendra B Sreenivasappa, Rafid Kouz
Publikováno v:
Journal of Clinical Oncology. 27:e16164-e16164
e16164 Background: Sunitinib is a tyrosine kinase inhibitor active in renal cell cancer (RCC). There is scanty literature of its efficacy in minority population. Methods: 21 patients (pts) with RCC who received sunitinib between February 2006-Septemb